# Multiple Myeloma Public Loop Completion Handoff v0

Stewarded by [frg.earth](https://frg.earth/).

- disease program: `multiple-myeloma`
- artifact id: `multiple-myeloma-public-loop-completion-handoff-v0`
- claim level: open-question
- handoff status: current public v0 loop endpoint
- clinical boundary: research-use-only, not medical advice
- completion boundary: public-loop completion, not scientific or clinical
  completion
- last reviewed: `2026-04-15`

## Purpose

This handoff closes the current public Clawdad v0 autonomous loop for the
multiple myeloma lane after the definition-of-complete audit and
case-specific private-lab blocker register.

It exists to prevent the next pass from inventing another schema, review
packet, case-processing, or tooling rung when the project-owned task queue is
empty and the remaining boundaries are private-lab or human-gated.

## Phase Handoff Guard

| Check | Finding | Handoff Decision |
| --- | --- | --- |
| Ready task queue | `make list-public-tasks ARGS="--status ready"` reported zero ready tasks before this handoff. | Do not select a new task by momentum. |
| Validation state | `make validate` passed after this handoff was wired, checking 182 JSON files. | Treat remaining work as a phase decision, not a broken artifact surface. |
| Named endpoint | [Case-Specific Private-Lab Blocker Register v0](case-specific-private-lab-blocker-register-v0.md) points to an aggregate completion handoff or final audit check. | This handoff is the current finite endpoint. |
| Task model language | The schema/tooling inventory says the next action after the blocker register should be aggregate completion handoff, not case-processing tooling. | Close the current v0 public loop rather than adding a downstream sibling. |
| Next unresolved range | The audit gap for `case_00` through `case_14` is resolved by the blocker register. | No new public case-stage range is selected. |
| Generalization opportunity | The remaining question spans roadmap, case-to-cure, source registry, validators, navigation, and blocked clinical lanes. | Use one aggregate handoff instead of extending a ladder. |

## Completion Matrix

| Definition-Of-Complete Criterion | Handoff Status | Public Basis | Residual Boundary |
| --- | --- | --- | --- |
| Every roadmap item has a public artifact, public task, schema, protocol, validator, or explicit blocked status. | Complete for the current v0 public roadmap. | Roadmap queue tasks are marked done; blocked tooling lanes are named by gates, handoffs, and the blocker register. | Future phases need a new project-owned gate or task queue. |
| The case-to-cure blueprint has public-safe schema summaries, gate checklists, and synthetic fixtures for each stage. | Complete for public v0 representation. | The blueprint, synthetic pipeline example, case-feature summary, candidate-option rubric, publication gate, review template, route-table fixtures, and blocker register cover the public-safe shape. | Real case work remains private-lab or human-gated. |
| The first multiple myeloma open research map is present and source-backed. | Complete for v0.1. | [Multiple Myeloma Open Research Map v0.1](open-research-map-v0-1.md) and its JSON companion are present. | The map is not comprehensive, expert-reviewed, or clinically actionable. |
| Source registry entries are sufficient for the first open research map. | Complete for v0.1. | [Source Registry v0](../../sources/source-registry-v0.md) includes public target, therapy, trial, regulatory, label, dataset, PubMed, ClinicalTrials.gov, FDA, NCI, and measurement anchors. | Source presence does not prove efficacy, safety, eligibility, availability, or patient fit. |
| Validators pass across metadata, catalogs, source links, task references, and schema examples. | Complete after this handoff is wired. | `make validate` passed after this handoff was added and cataloged. | Re-run validation before any future phase or release edit. |
| Public README and catalog paths make the work navigable. | Complete after this handoff is wired. | The disease-program README, public roadmap, schema/tooling inventory, and public artifact catalog link the v0 lane and this handoff. | Navigation does not imply clinical readiness or publication readiness. |
| All remaining case-specific steps are represented as private-lab tasks or human-gated blockers. | Complete for public v0 representation. | [Case-Specific Private-Lab Blocker Register v0](case-specific-private-lab-blocker-register-v0.md) maps `case_00` through `case_14`. | Public case processing remains blocked. |

## Handoff Decision

The current multiple myeloma public v0 loop is semantically complete for the
definition-of-complete criteria in
[Clawdad Autonomous Research Loop v0](../../protocols/clawdad-autonomous-research-loop-v0.md).

No ready public task is selected by this handoff.

The next action should be human review, publication preparation outside the
autonomous loop, or a newly named public phase with its own aggregate gate and
task model. Any future phase must start by re-checking validation, public
safety boundaries, source coverage, and whether the intended work is
project-owned.

## Still Blocked

The following remain blocked in the public repo:

- real case intake or case upload
- patient-identifying data, private records, dates tied to a person, images,
  free-text notes, record paths, or re-identification keys
- review-packet assembly or generated review-packet output
- generated biomedical claims or generated clinical summaries
- patient matching, trial matching, eligibility guidance, availability
  guidance, candidate-option ranking, target prioritization, or treatment
  recommendations
- expanded-access guidance, monitoring instructions, stop rules, dose or
  schedule guidance, or safety-management advice
- publication workflow for case-derived learning without private privacy,
  safety, review, and publication gates
- clinical, legal, regulatory, sponsor, institutional, treating-team, or
  publication decisions
- unsupported cure or vaccine claims

## Allowed Future Starts

Future work may begin only as a new named phase or human-reviewed task model.
Examples of acceptable starts include:

- a human-reviewed public release checklist for the existing v0 artifacts
- a new source-backed map-expansion phase with explicit source and validator
  requirements
- a new aggregate tooling gate that proves validated inputs, no-generated-claim
  behavior, no-patient matching, and no-ranking boundaries before any code
- a blocker note when the next requested work requires private data, external
  decisions, paid services, credentials, or clinical judgment

## Public Safety Check

- No patient-identifying data.
- No real case data.
- No private records.
- No credentials, paid APIs, account changes, or restricted datasets.
- No patient-specific diagnosis, prognosis, treatment, trial, expanded-access,
  monitoring, or candidate-option guidance.
- No target, therapy, trial, source, mechanism, artifact, task, or evidence
  ranking.
- No generated biomedical claims.
- No expert-review substitution.
- No publication authorization.
- No cure claim.

## Limitations

- This handoff does not prove the science is complete.
- This handoff does not prove source coverage is comprehensive.
- This handoff does not make any artifact expert-reviewed.
- This handoff does not make any artifact publication-ready.
- This handoff does not inspect private lab records or real case data.
- This handoff does not complete any private-lab task or human-gated decision.
- This handoff does not authorize review-packet assembly, generated packet
  output, generated claims, ranking, recommendation behavior, patient matching,
  trial matching, or publication workflow.
- This handoff does not authorize public case processing or public case data
  upload.
- This handoff does not provide medical advice, diagnostic guidance, treatment
  guidance, trial guidance, eligibility guidance, expanded-access guidance,
  monitoring guidance, or a cure claim.
